| Dr Rhonda Lee Lindsey, PSYD | |
|
1049 4th Street, Suite G, Santa Rosa, CA 95404 | |
| (707) 608-8841 | |
| (707) 571-9796 |
| Full Name | Dr Rhonda Lee Lindsey |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 28 Years |
| Location | 1049 4th Street, Santa Rosa, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831245737 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY15314 (California) | Primary |
| Entity Name | Lomi School Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437171543 PECOS PAC ID: 0345131512 Enrollment ID: O20040324001563 |
News Archive
Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rhonda Lee Lindsey, PSYD 1049 4th Street, Suite G, Santa Rosa, CA 95404 Ph: (707) 608-8841 | Dr Rhonda Lee Lindsey, PSYD 1049 4th Street, Suite G, Santa Rosa, CA 95404 Ph: (707) 608-8841 |
News Archive
Researchers from Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility.
Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.
An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Surgery to cut part of the nerves to the heart can reduce the risk of fainting or sudden death in young people with a heart rhythm disorder called long QT syndrome (LQTS), researchers reported in today's rapid access issue of Circulation: Journal of the American Heart Association.
› Verified 2 days ago
Dr. Andrew M Leeds, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1049 4th St Ste G, Santa Rosa, CA 95404 Phone: 707-579-9457 Fax: 707-579-4515 | |
Dr. Cynthia Carole Berman, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-3722 | |
James Fisher Taylor, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-3720 | |
Sara Joslyn, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 825 College Ave, Santa Rosa, CA 95404 Phone: 707-545-2426 | |
Mrs. Pamela A Boaz, PHD MFT Psychologist Medicare: Not Enrolled in Medicare Practice Location: 659 Cherry St, Santa Rosa, CA 95404 Phone: 707-526-8300 Fax: 707-526-8310 | |
Edward A Biery, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1144 Sonoma Ave, Ste 104, Santa Rosa, CA 95405 Phone: 707-595-8680 | |
Dr. Deborah Lynn Chiddix, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 434 Earle St, Santa Rosa, CA 95404 Phone: 707-696-6620 |